Cleared Traditional

K922345 - TESTPACK PLUS STREP A

K922345 is an FDA 510(k) clearance for TESTPACK PLUS STREP A, manufactured by Abbott Laboratories. The device is a Class 1 Microbiology device with product code GTZ cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K922345 · Abbott Laboratories · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1992
Decision
58d
Days
Class 1
Risk

K922345 is an FDA 510(k) clearance for the TESTPACK PLUS STREP A. Classified as Antisera, All Groups, Streptococcus Spp. (product code GTZ), Class I - General Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on July 16, 1992 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K922345

510(k) Number K922345 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 19, 1992
Decision Date July 16, 1992
Days to Decision 58 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
44d faster than avg
Panel avg: 102d · This submission: 58d
Pathway characteristics
Predicate-based equivalence.

GTZ Device Classification - Class 1, General Controls

Product Code GTZ Antisera, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTZ Antisera, All Groups, Streptococcus Spp.

All 81
Devices cleared under the same product code (GTZ) and FDA review panel - the closest regulatory comparables to K922345.
QUICKVUE IN-LINE ONE-STEP STREP A TEST
K934484 · Quidel Corp. · Jul 1994
STREP A NEGATIVE CONTROL
K924461 · Pacific Biotech, Inc. · Dec 1993
QUIKPAC STREP A TEST
K924007 · Syntron Bioresearch, Inc. · Apr 1993
BBL STREP GROUPING KIT
K920565 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Mar 1992
STREP A OIA
K915758 · Biosearch Medical Products, Inc. · Jan 1992
OIA STREP A
K912889 · Biosearch Medical Products, Inc. · Oct 1991